Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.98 HKD | +2.95% | +0.43% | +4.49% |
15/04 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
15/04 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
ETFs positioned on Ocumension Therapeutics
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.59% | 4 M€ | -27.92% | ||
0.00% | 34 M€ | +3.96% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.49% | 602M | |
+38.71% | 728B | |
+33.05% | 603B | |
-6.14% | 360B | |
+18.65% | 332B | |
+1.13% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.18% | 164B |
- Stock Market
- Equities
- 1477 Stock
- Funds and ETFs Ocumension Therapeutics